Fig. 6: Correlation of malignant NSCLC with the expression of key genes in the MVA pathway. | Cell Death & Disease

Fig. 6: Correlation of malignant NSCLC with the expression of key genes in the MVA pathway.

From: MiR-122-5p regulates the mevalonate pathway by targeting p53 in non-small cell lung cancer

Fig. 6

HMGCS1, HMGCR, and FDFT1 protein expression in tumor tissues of p53 wild-type NSCLC patients with different cancer stages by IHC staining (A) (×40 magnification) and the bar graph corresponding to A of their expression (B). p53 wild-type NSCLC cancers with different degrees of differentiation by HE, HMGCS1, HMGCR, and FDFT1 by IHC staining (C) (×40 magnification) and the bar graphs of their expression (D). AOD values were measured from positive areas of three randomly selected different fields of view (mean ± SD), ns not significant, *P < 0.05 and **P < 0.01.

Back to article page